Non Invasive Methods to Guide Volume Optimization
Launched by LENA NILSSON · Oct 24, 2011
Trial Information
Current as of May 17, 2025
Completed
Keywords
ClinConnect Summary
The patients are not allowed to eat after midnight. Routine premedication is given with paracetamol and oxynorm/oxycontin. Thrombosis and antibiotic prophylaxis is given according to surgical department.
The weight of the patient is notices on the morning of surgery (day 0).
The patient arrives in the morning to the preoperative area. A urinary analysis is taken for urinary colour, creatinine, specific weight, osmolality, microalbuminuria and electrolytes. For 30 patients a volume kinetic analysis of 5 ml/kg infusion of acetated Ringers solution is undertaken between 6.30 and 8.00 am on t...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Open abdominal surgery under general anaesthesia with a planned operation time of at least 120 minutes
- • 2. Age ≥ 18 years
- Exclusion Criteria:
- • 1. Anaesthesia risk classification ASA ≥ 4
- • 2. Arrhythmia; atrial fibrillation or multiple extra systoles
- • 3. Aortic - or mitral insufficiency with hemodynamic influence
- • 4. Patients who at the preoperative visit by the responsible anaesthesiologist is planned for a more advanced cardiovascular monitoring. The following monitoring is accepted in the study: invasive blood pressure, 5-lead ECG, central venous pressure and urinary output per hour.
- • 5. Patients with a pulmonary or other disease that prevents ventilation using a tidal volume of 7 ml/kg (ideal weight) or a positive end expiratory pressure of 5 -10 cm H2O
- • 6. Contra indication against synthetic colloids as severely impaired renal or liver function, hyper natremia or allergy to synthetic colloids
- • 7. Laparoscopic surgery
- • 8. Liver surgery
- • 9. Surgery including thoracotomy
- • 10. Contraindications against an oesophageal probe such as severe oesophageal varicose veins
About Lena Nilsson
Lena Nilsson is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapies and evidence-based practices, Lena Nilsson leads the design and implementation of trials that address unmet medical needs across various therapeutic areas. The organization prioritizes ethical standards, patient safety, and rigorous scientific methodologies, collaborating with healthcare professionals and research institutions to ensure the highest quality of clinical data. Through its strategic partnerships and commitment to excellence, Lena Nilsson aims to contribute significantly to the development of groundbreaking treatments and enhance the overall landscape of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Linköping, , Sweden
Patients applied
Trial Officials
Lena Nilsson, MD PhD
Principal Investigator
Anestesi- och operationskliniken, Universitetssjukuset, SE 58183 Linköping, Sweden
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials